Skip to content
FIND A BIOALPS ACTOR
Netsensing Technology

Netsensing Technology | SmartEEs2 (EU H2020) contracting phase

18.03.2021
Share this article

The EU consortium will reinforce its penetration to global market & its position with EU partners

 

Incubated at Microcity, Netsensing Technology Sàrl is excited to announce that after last year successful round of private investment and EU H2020 Digi-B-Cube grant, a new important step of the development of its automatic sleep apnea scoring cloud-based medical device: The Home Sleep Apnea Test (HSAT) device that Netsensing is developing, has been selected to be accelerated by a European H2020 programme called SmartEEs2.

Netsensing solution ambition is to enable the mass detection of sleep apnea with its wearable and low-cost device, that drastically reduces time and cost of detection and, is easy to use.

 

About Netsensing Technology Sàrl

Netsensing Technology Sàrl is a privately held medical device company incorporated in 2019. It was selected by Bilan top 50 startups in 2019, received the Seal of Excellence from the European Union, won EU H2020 Digi-B-Cube grant No. 824920 and, was “Prix BCN Innovation” finalist in 2020. It focuses on enabling the mass detection of sleep apnea with an extremely affordable wearable Home Sleep Apnea Test device, compliant with the American Academy of Sleep Medicine (AASM) requirements and, targeted as a class IIa medical device.

 

About SmartEEs2

The SmartEEs2 project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 872076.

 

Press release